Piper Sandler, a well-known investment firm, increased its price target on shares of Amgen (NASDAQ:AMGN) to $329.00, up from the previous target of $310.00. The firm has maintained its Overweight ...
Aflac (NYSE:AFL – Free Report) had its price objective decreased by Piper Sandler from $122.00 to $118.00 in a research note ...
Piper Sandler Companies PIPR has announced a new share repurchase plan. The board of directors has approved the repurchase of up to $150 million worth of shares of PIPR’s outstanding stock.
The U.S. Securities and Exchange Commission's (SEC) newly established Crypto Task Force is expected to provide much-needed regulatory clarity for institutional investors, according to a research note ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...
Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm with a market capitalization of $5.1 billion, has demonstrated robust performance and strategic ...
Piper Sandler analyst Christopher Raymond maintained a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) today and set a price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results